Exclusive interview with generic drug lobby CEO

AAM: Tariffs Would Block Shared Goals Of Generic Drug Makers & Trump Admin

By Gabrielle Wanneh / January 9, 2025 at 6:31 PM

The U.S. generic drug lobby hopes to convince the incoming Trump administration that imposing tariffs on imported medical products would hurt generic drug makers and hinder their shared goal of lowering drug prices, Association for Accessible Medicines CEO John Murphy tells Inside Health Policy in an exclusive interview.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.